Verge Genomics
YC S15San Francisco, US · Founded 2015 · 50 employees · Hiring · 12 known investors
Verge Labs builds AI models trained on multimodal human patient data to predict drug targets and patient populations for clinical development, primarily in neuroscience and central nervous system (CNS) disease. The company applies frontier AI techniques to drug discovery for life sciences and pharmaceutical development.
AI & Machine LearningBiotechDeep TechDigital HealthHealthtechUnited States of AmericaAmerica / CanadaPartly Remote
Founders & leadership· Y Combinator alumni (S15)
Verge Genomics was founded in 2015 by Alice Zhang and Jason Chen.
AZ
JC
Jason ChenCofounder30 Under 30 2020
ER
Emily RipkaHead of Product & Engineering
Investors · 12
BOLD LongevityBoston
Draper AssociatesSan Mateo · $500K – $5M
Fitz Gate VenturesHouston · $500K – $1M
Great Oaks Venture CapitalNew York · $50K – $500K
Karlin VenturesLos Angeles · $250K – $2M
Lifeforce CapitalChevy Chase · $500K – $5M
Tenmile
WorldQuant VenturesOld Greenwich
Y CombinatorSan Francisco · $500K
Agent CapitalreportedWaltham
Basis Set VenturesreportedMenlo Park · $1M – $3M
OS FundreportedPark Ridge · $1M – $2M
Images
Competitors · 5
by search overlapLeadIQ7 shared keywordsLeadIQ offers a company search tool that provides B2B company profiles with data such as revenue, employee count, funding, and contact information to help sales teams find decision makers and build pipeline.
Polaris Genomics7 shared keywordsPolaris Genomics is a Veteran-owned biotech startup mapping molecular biomarkers to develop objective, biologically-based diagnostics and novel therapeutics for mental health and neuropsychiatric conditions such as PTSD. It combines genomics and AI to advance precision mental health care.
Genomics Plc6 shared keywordsGenomics builds a genotype-phenotype database and genetic risk-prediction tools used to support pharmaceutical drug discovery and clinical trials, as well as population health management and clinical decision support for healthcare providers. It serves life sciences companies and healthcare systems through its Life Sciences and Health & Wellness divisions.
Verge HealthTech Fund5 shared keywordsVerge is a venture capital firm that invests in healthtech founders, backed by former operators and investors. It maintains a global network of clinicians, scientists, and operators to help portfolio companies scale.
Rev Genomics5 shared keywordsRev Genomics uses genomic selection, tissue culture, and molecular analysis to develop high-value crop cultivars for breeders and seed banks. The company creates novel plant phenotypes and provides molecular fingerprinting and breeding technology primarily for specialty crops in California.
Companies competing with Verge Genomics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Verge Genomics do?
- Verge Labs builds AI models trained on multimodal human patient data to predict drug targets and patient populations for clinical development, primarily in neuroscience and central nervous system (CNS) disease. The company applies frontier AI techniques to drug discovery for life sciences and pharmaceutical development.
- Who founded Verge Genomics?
- Verge Genomics was founded by Alice Zhang, Jason Chen in 2015.
- Who are Verge Genomics's investors?
- Verge Genomics's investors include BOLD Longevity, Draper Associates, Fitz Gate Ventures, Great Oaks Venture Capital, Karlin Ventures, Lifeforce Capital, Tenmile, WorldQuant Ventures and 4 more.
- Where is Verge Genomics headquartered?
- Verge Genomics is headquartered in San Francisco, US.